Pharma Promotion / Incidents by company / Pfizer
Pfizer
59 incidents / jurisdictions: European Union, United Kingdom, United States / sum of amounts reported: GBP 63.0 m / USD 8.58 bn
| Date | Jurisdiction | Outcome | What happened (source) | Damages / settlement / fine |
|---|---|---|---|---|
| 2025-01-24 | United States | Settlement | Pfizer Agrees to Pay Nearly 60M to Resolve False Claims Allegations Relating to Improper Physician Payments by Subsidiary U.S. Department of Justice + 1 more reports | $59,746,277 / $60 million |
| 2022-07-25 | United States | Filed / under investigation | Pfizer, Inc. v. HHS Court of Appeals for the Second Circuit | — |
| 2022 | United Kingdom | Fine / administrative sanction | In July 2022, UK antitrust authorities fined Pfizer £63 million for unfairly pricing a drug that aids in controlling epileptic seizures. The Competition and Markets Authority stated that the company a Wikipedia: Pfizer（Legal issues） + 1 more reports | £63 million |
| 2022 | European Union | Filed / under investigation | In August 2022, Moderna announced that it will sue Pfizer and its partner BioNTech for infringing its patent on the mRNA technology. In May 2024, the European Patent Office upheld the validity of Mode Wikipedia: Pfizer（Legal issues） | — |
| 2019-03-14 | United States | Filed / under investigation | Martinez v. Pfizer Inc. District Court, W.D. Texas | — |
| 2018-05-24 | United States | Settlement | Pfizer Agrees to Pay $23.85 Million to Resolve Allegations that it Paid Kickbacks Through a Co-Pay Assistance Foundation U.S. Department of Justice + 1 more reports | $23.85 Million |
| 2018-04-13 | United States | Filed / under investigation | Al Haj v. Pfizer Inc. District Court, E.D. Illinois | — |
| 2017-01-30 | United States | Settlement | United States Ex Rel. Booker v. Pfizer, Inc. Court of Appeals for the First Circuit + 1 more reports | — |
| 2016-05-23 | United States | Filed / under investigation | United States ex rel. Booker v. Pfizer, Inc. District Court, D. Massachusetts + 1 more reports | — |
| 2016-05-17 | United States | Judgment for company / dismissed | United States ex rel. Polansky v. Pfizer Court of Appeals for the Second Circuit + 1 more reports | — |
| 2016-04-27 | United States | Settlement | Wyeth and Pfizer Agree to Pay $784.6 Million to Resolve Lawsuit Alleging that Wyeth Underpaid Drug Rebates to Medicaid U.S. Department of Justice + 3 more reports | $784.6 Million |
| 2014-08-06 | United States | Judgment for company / dismissed | United States ex rel. Polansky v. Pfizer, Inc. Court of Appeals for the Second Circuit + 1 more reports | — |
| 2014-03-26 | United States | Filed / under investigation | United States v. Pfizer, Inc. District Court, D. Massachusetts | — |
| 2014-03-26 | United States | Filed / under investigation | United States v. Pfizer, Inc. District Court, D. Massachusetts | — |
| 2013-07-30 | United States | Settlement | Wyeth Pharmaceuticals Agrees to Pay $490.9 Million for Marketing the Prescription Drug Rapamune for Unapproved Uses U.S. Department of Justice | — |
| 2013-04-03 | United States | Judgment against company | Aetna, Inc. v. Pfizer, Inc. Court of Appeals for the First Circuit | — |
| 2013-04-03 | United States | Other | Harden Manufacturing Corp. v. Pfizer, Inc. Court of Appeals for the First Circuit | — |
| 2013-04-03 | United States | Judgment against company | Kaiser Foundation Health Plan, Inc. v. Pfizer, Inc. Court of Appeals for the First Circuit | $140 million |
| 2013 | United States | Settlement | The Quigley Company, which sold asbestos -containing insulation products until the early 1970s, was acquired by Pfizer in 1968. In June 2013, asbestos victims and Pfizer negotiated a settlement that r Wikipedia: Pfizer（Legal issues） + 1 more reports | $964 million / $430 million |
| 2012-12-19 | United States | Filed / under investigation | Pfizer Inc. v. Oregon Department of Justice Court of Appeals of Oregon | — |
| 2012-12-12 | United States | Settlement | Pfizer Agrees to Pay $55 Million for IllegallyPromoting Protonix for Off-Label Use U.S. Department of Justice + 1 more reports | $55 Million |
| 2012-11-15 | United States | Filed / under investigation | United States ex rel. Polansky v. Pfizer, Inc. District Court, E.D. New York | — |
| 2012-08-07 | United States | Settlement | Pfizer H.C.P. Corp. Agrees to Pay $15 Million Penalty to Resolve Foreign Bribery Investigation U.S. Department of Justice | $15 Million / $26.3 m |
| 2012-07-25 | United States | Filed / under investigation | United States ex rel. Wenzel v. Pfizer, Inc. District Court, D. Massachusetts | — |
| 2012 | United States | Settlement | Brigham Young University (BYU) said a professor of chemistry, Dr. Daniel L. Simmons , discovered an enzyme in the 1990s that led towards development of Celebrex . BYU was originally seeking a 15% roya Wikipedia: Pfizer（Legal issues） | — |
| 2012 | United States | Settlement | Brigham Young University (BYU) said a professor of chemistry, Dr. Daniel L. Simmons , discovered an enzyme in the 1990s that led towards development of Celebrex . BYU was originally seeking a 15% roya Wikipedia: Pfizer（Celebrex intellectual property settlement (2012)） | — |
| 2011-10-21 | United States | Settlement | Pfizer to Pay $14.5 Million for Illegal Marketing of Drug Detrol U.S. Department of Justice | $14.5 Million / $2.3 billion |
| 2011-08-31 | United States | Judgment against company | Kaiser Foundation Health Plan, Inc. v. Pfizer, Inc. District Court, D. Massachusetts | $95,286,518 |
| 2011-07-27 | United States | Judgment against company | Kaiser Foundation Health Plan, Inc. v. Pfizer, Inc. District Court, D. Massachusetts | — |
| 2011-04-29 | United States | Filed / under investigation | In Re Pfizer Inc. Shareholder Derivative Litigation District Court, S.D. New York | — |
| 2011 | United States | Settlement | The lawsuits were eventually settled out of court. Pfizer committed to paying US$35 million "to compensate the families of children in the study", another $30 million to "support healthcare initiative Wikipedia: Pfizer（Nigeria Trovafloxacin lawsuit settlement (2011)） | US$35 million |
| 2010-09-14 | United States | Filed / under investigation | United States Ex Rel. Rost v. Pfizer, Inc. District Court, D. Massachusetts | — |
| 2010-07-20 | United States | Filed / under investigation | Zafarana v. Pfizer Inc. District Court, E.D. Pennsylvania | — |
| 2010-07-13 | United States | Filed / under investigation | In Re Pfizer Inc. Shareholder Derivative Litigation District Court, S.D. New York | — |
| 2010-04-29 | United States | Filed / under investigation | Smith v. Pfizer Inc. District Court, M.D. Tennessee | — |
| 2010-02-19 | United States | Filed / under investigation | Smith v. PFIZER INC. District Court, M.D. Tennessee | — |
| 2010-01-19 | United States | Judgment for company / dismissed | Clark v. PFIZER INC. Superior Court of Pennsylvania | — |
| 2010-01-08 | United States | Filed / under investigation | Guardian Life Insurance Co. of America v. Pfizer, Inc. District Court, D. Massachusetts | — |
| 2010 | United States | Filed / under investigation | In June 2010, health insurance network Blue Cross Blue Shield (BCBS) filed a lawsuit against Pfizer for allegedly illegally marketing drugs Bextra, Geodon and Lyrica. BCBS alleged that Pfizer used kic Wikipedia: Pfizer（Legal issues） + 1 more reports | — |
| 2010 | United States | Judgment against company | In June 2010, the US Supreme Court rejected Pfizer's appeal against a ruling allowing lawsuits by the Nigerian families to proceed. Wikipedia: Pfizer（Legal issues） + 1 more reports | — |
| 2010 | United States | Other | In December 2010, the United States diplomatic cables leak indicated that Pfizer hired investigators to find evidence of corruption against Nigerian attorney general Michael Aondoakaa to persuade him Wikipedia: Pfizer（Legal issues） + 1 more reports | — |
| 2009-05-13 | United States | Filed / under investigation | In re Neurontin Marketing, Sales Practices & Products Liability Litigation District Court, D. Massachusetts | — |
| 2009 | United States | Settlement | 2009 | Pfizer | $2.3 billion | Off-label promotion, kickbacks | Bextra , Geodon , Zyvox , Lyrica | False Claims Act, FDCA Wikipedia: List of largest pharmaceutical settlements + 2 more reports | $2.3 billion / $1.195 billion / $1.0 billion |
| 2008-09-18 | United States | Filed / under investigation | United States ex rel. Rost v. Pfizer, Inc. District Court, D. Massachusetts | — |
| 2008-02-29 | United States | Filed / under investigation | Kwaak v. Pfizer, Inc. Massachusetts Appeals Court | — |
| 2007-11-15 | United States | Judgment for company / dismissed | United States Ex Rel. Rost v. Pfizer, Inc. Court of Appeals for the First Circuit | — |
| 2007-07-05 | United States | Judgment for company / dismissed | Baron v. Pfizer, Inc. Appellate Division of the Supreme Court of the State of New York | — |
| 2006-08-30 | United States | Filed / under investigation | United States Ex Rel. Rost v. Pfizer Inc. District Court, D. Massachusetts | — |
| 2006-06-23 | United States | Filed / under investigation | Southern v. Pfizer, Inc. District Court, N.D. Alabama | — |
| 2005-08-26 | United States | Filed / under investigation | Caggiano v. Pfizer, Inc. District Court, S.D. New York | — |
| 2005 | United States | Judgment for company / dismissed | Peter Rost was vice president in charge of the endocrinology division at Pharmacia before its acquisition by Pfizer. During that time he raised concerns internally about kickbacks and off-label market Wikipedia: Pfizer（Legal issues） | — |
| 2005 | United States | Settlement | A "whistleblower suit" was filed in 2005 against Wyeth , which was acquired by Pfizer in 2009, alleging that the company illegally marketed sirolimus (Rapamune) for off-label uses , targeted specific Wikipedia: Pfizer（Legal issues） + 1 more reports | $491 million |
| 2004-03-24 | United States | Filed / under investigation | Rubel, Janet v. Pfizer, Incorporated Court of Appeals for the Seventh Circuit | — |
| 2004 | United States | Settlement | 2004 | Pfizer | $430 million | Off-label promotion | Neurontin | False Claims Act, FDCA Wikipedia: List of largest pharmaceutical settlements | $430 million |
| 2003-08-12 | United States | Filed / under investigation | Rubel v. Pfizer Inc. District Court, N.D. Illinois | — |
| 2001 | European Union | Fine / administrative sanction | In March 2001 the license for Trovan was withdrawn in Europe, by the European Commission due to liver toxicity and some deaths. Wikipedia: Pfizer（Legal issues） + 1 more reports | — |
| 1994 | United States | Settlement | Pfizer purchased Shiley in 1979, at the onset of its Convexo-Concave valve ordeal, involving the Bjork–Shiley valve . Approximately 500 people died when defective heart valves fractured and, in 1994, Wikipedia: Pfizer（Legal issues） + 1 more reports | $10.75 million |
| 1993 | United States | Settlement | In 1993, the Food and Drug Administration (FDA) approved gabapentin only for treatment of seizures . Warner–Lambert , which merged with Pfizer in 2000, used continuing medical education and medical re Wikipedia: Pfizer（Legal issues） | $430 million |
| 1993 | United States | Settlement | In 1993, the Food and Drug Administration (FDA) approved gabapentin only for treatment of seizures . Warner–Lambert , which merged with Pfizer in 2000, used continuing medical education and medical re Wikipedia: Pfizer（Illegal marketing of gabapentin for off-label uses settlement (2004)） | $430 million |
Amounts are extracted mechanically from headlines and summaries and kept only when Jev confirms they are paid by the company. The same case reported by several articles may be counted more than once, so totals are indicative. Check the sources.